Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
- Citation:
- Cancer vol 120 (15) 2325-2333
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 4
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- R01 CA102613, U10 CA180821
- Corr. Author:
- Authors:
- Heikki Joensuu Mikael Eriksson Kirsten Sundby Hall Jörg T Hartmann Daniel Pink Jochen Schütte Giuliano Ramadori Peter Hohenberger Justus Duyster Salah-Eddin Al-Batran Marcus Schlemmer Sebastian Bauer Eva Wardelmann Maarit Sarlomo-Rikala Bengt Nilsson Harri Sihto Karla V Ballman Mika Leinonen Ronald P DeMatteo Peter Reichardt
- Networks:
- Study
- ACOSOG-Z9001
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- gastrointestinal stromal tumor, imatinib, adjuvant therapy, predictive score